InTest reports preliminary Q2 rev ~$35M (above guidance), gross margin ~40% (miss); revises Q1 gross margin down 220 bps

INTEST CORP

Q2 revenue ~$35M, above guidance of $32-34M; gross margin ~40%, below guidance of ~45%.
Q1 gross margin overstated by ~$750k (220 bps) due to ERP implementation issues at Alfamation; revision to be made.
FY2026 revenue guidance raised to $135-140M (from $130-135M); gross margin guidance lowered to ~43% (from ~45%).
Company expects to report a material weakness in internal control over financial reporting, but believes remediated.
Operating expenses for Q2 estimated at $13.9M, within guidance range.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.